Rennova Health, Inc.

RNVAOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$4305132

P/E Ratio—

52W High$0.0001

52W Low$0.0001

Avg Volume1.0M

Open$0.00

Beta-0.05

Overview

Rennova Health, Inc. (RNVA) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

RNVA · free cash flow · updated Jun 15, 2026

Core FCF metrics

RNVA · FCF · TTM · margin & CAGR

Free cash flow was $3.0M for FY2023 (fiscal year ending 2023-12-31), up 1297.6% year-over-year The FCF margin was 16.3%.

FY2023 Free Cash Flow$3.0M▲ +1297.6% YoY

Trailing 12M (TTM)$3.0Mtrailing 4 quarters sum

FCF Margin16.3%$3.0M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

RNVA · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2023Latest$3.4M(0M)$3.0M▲ +1297.6%16.3%

FY2022−$218,348(0M)−$253,578▲ +97.2%-1.9%

FY2021−$8.9M(0M)−$8.9M▲ +48.5%-276.5%

FY2020−$16.9M(0M)−$17.3M▼ 27.9%-240.3%

FY2019−$13.5M(0M)−$13.5M▼ 71.4%-84.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

RNVA · P/FCF · FCF yield · FCF per share

Rennova Health, Inc. (RNVA) trades at a FCF yield of 70.54% and a price-to-free-cash-flow ratio of N/A. FCF per share stands at $0.00, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

70.54%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.00

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

x5.3

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2023 · 2023-12-31

Cash flow statement summary

RNVA · cash flow statement · operating / investing / financing

For FY2023, Rennova Health, Inc. generated $3.4M in operating cash flow and spent 0M in capital expenditures, yielding $3.0M in free cash flow.

Operating Activities

+$3.4M

Cash from core business operations

2023-12-31

Investing Activities

−$1.5M

CapEx, acquisitions & investments

2023-12-31

Financing Activities

−$2.3M

Buybacks, dividends & debt

2023-12-31

FCF FormulaOperating CF ($3.4M) − |CapEx| (0M) = FCF ($3.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

RNVA vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Rennova Health, Inc.YOU

RNVA

$3.0M+1297.6%16.3%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Rennova Health, Inc. (RNVA) reported free cash flow of $3.0M for FY2023 (fiscal year ending 2023-12-31), up 1297.6% year-over-year. The FCF margin was 16.3%.

Based on available data, Rennova Health, Inc. has maintained positive free cash flow for at least 1 fiscal year(s). FCF peaked at $3.0M in FY2023.

Rennova Health, Inc.'s FCF yield is 70.54% and price-to-FCF ratio is N/A for FY2023, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

RNVA free cash flow · 8 questions

Rennova Health, Inc. free cash flow was $3.0M for FY2023, up 1297.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $3.0M.

RNVA free cash flowRNVA FCFRNVA FCF 2023RNVA free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Rennova Health, Inc. · Rennova Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026